UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study

The lancet oncology, 2021-07, Vol.22 (7), p.919-930

2021

Volltextzugriff (PDF)

Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study

Advances in radiation oncology, 2024-08, Vol.9 (8), p.101532, Article 101532

2024

Volltextzugriff (PDF)

Intermedin is overexpressed in hepatocellular carcinoma and regulates cell proliferation and survival

Cancer science, 2012-08, Vol.103 (8), p.1474-1480

2012

Volltextzugriff (PDF)

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Nature medicine, 2024-08, Vol.30 (8), p.2216-2223

2024

Volltextzugriff (PDF)

Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Nature medicine, 2024-08, Vol.30 (8), p.2372-2372

2024

Volltextzugriff (PDF)

Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Nature medicine, 2024-08, Vol.30 (8), p.2377-2377

2024

Volltextzugriff (PDF)

Molecular markers and mortality in prostate cancer

BJU international, 2007-12, Vol.100 (6), p.1259-1263

2007

Volltextzugriff (PDF)

Management of Advanced Prostate Cancer in Clinical Practice: Real-World Answers to Challenging Dilemmas

JCO oncology practice, 2020-12, Vol.16 (12), p.783-789

2020

Volltextzugriff (PDF)

Comparison of Perioperative Outcomes for Radical Nephrectomy Based on Surgical Approach for Masses Greater Than 10 cm

Journal of endourology, 2021-12, Vol.35 (12), p.1785-1792

2021

Volltextzugriff (PDF)

Robotic-assisted prostatectomy and open radical retropubic prostatectomy for locally-advanced prostate cancer: multi-institution comparison of oncologic outcomes

Prostate international, 2013-03, Vol.1 (1), p.31-36

2013

Volltextzugriff (PDF)

Laparoscopic Repair of Inguinal Cystocele Using Cystoscopic Light Test

Urology (Ridgewood, N.J.), 2012-03, Vol.79 (3), p.725-727

2012

Volltextzugriff (PDF)

Tissue Microarray Analysis of 560 Patients with Colorectal Adenocarcinoma: High Expression of HuR Predicts Poor Survival

Annals of surgical oncology, 2009, Vol.16 (1), p.200-207, Article 200

2009

Volltextzugriff (PDF)

When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?

Current pharmacology reports, 2015-12, Vol.1 (6), p.420-433

2015

Volltextzugriff (PDF)

Impact of biochemical recurrence in prostate cancer among US veterans

Archives of internal medicine (1960), 2010-08, Vol.170 (15), p.1390

2010

Volltextzugriff (PDF)

Poliomyelitis in MuLV-Infected ICR-SCID Mice after Injection of Basement Membrane Matrix Contaminated with Lactate Dehydrogenase-Elevating Virus

Comparative medicine, 2011-10, Vol.61 (5), p.404-411

2011

Volltextzugriff (PDF)

A phase II study to evaluate the effects of docetaxel plus lycopene in advanced castrate-resistant prostate cancer

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.77-77

2021

Volltextzugriff (PDF)

Laparoscopic Management of Extra-Adrenal Pheochromocytoma

The Journal of urology, 2004, Vol.171 (1), p.72-76

2004

Volltextzugriff (PDF)

Final results of CORE-001: A phase-2, single arm study of cretostimogene grenadenorepvec in combination with pembrolizumab in patients with BCG-unresponsive, non-muscle invasive bladder cancer with carcinoma in situ

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.4601-4601

2024

Volltextzugriff (PDF)

ENLIGHTED phase 3 study: Efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) for treatment of low-grade upper tract urothelial cancer (LG UTUC)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.TPS4622-TPS4622

2024

Volltextzugriff (PDF)

QS96. Aging Effects on The Von Hippel Lindau (VHL) Tumor Suppressor Pathway in The Development of Renal Carcinoma

The Journal of surgical research, 2008, Vol.144 (2), p.305-306

2008

Volltextzugriff (PDF)

Treatment decisions and outcomes for NCCN favorable intermediate-risk prostate cancer patients after receiving the 17-gene genomic prostate cancer score result

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.218-218

2021

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study

A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial

Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial

Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup

Intermedin is overexpressed in hepatocellular carcinoma and regulates cell proliferation and survival

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial

Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Molecular markers and mortality in prostate cancer

Management of Advanced Prostate Cancer in Clinical Practice: Real-World Answers to Challenging Dilemmas

Comparison of Perioperative Outcomes for Radical Nephrectomy Based on Surgical Approach for Masses Greater Than 10 cm

Robotic-assisted prostatectomy and open radical retropubic prostatectomy for locally-advanced prostate cancer: multi-institution comparison of oncologic outcomes

Laparoscopic Repair of Inguinal Cystocele Using Cystoscopic Light Test

Tissue Microarray Analysis of 560 Patients with Colorectal Adenocarcinoma: High Expression of HuR Predicts Poor Survival

When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?

Impact of biochemical recurrence in prostate cancer among US veterans

Poliomyelitis in MuLV-Infected ICR-SCID Mice after Injection of Basement Membrane Matrix Contaminated with Lactate Dehydrogenase-Elevating Virus

A phase II study to evaluate the effects of docetaxel plus lycopene in advanced castrate-resistant prostate cancer

Laparoscopic Management of Extra-Adrenal Pheochromocytoma

Final results of CORE-001: A phase-2, single arm study of cretostimogene grenadenorepvec in combination with pembrolizumab in patients with BCG-unresponsive, non-muscle invasive bladder cancer with carcinoma in situ

ENLIGHTED phase 3 study: Efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) for treatment of low-grade upper tract urothelial cancer (LG UTUC)

QS96. Aging Effects on The Von Hippel Lindau (VHL) Tumor Suppressor Pathway in The Development of Renal Carcinoma

Treatment decisions and outcomes for NCCN favorable intermediate-risk prostate cancer patients after receiving the 17-gene genomic prostate cancer score result

Suchergebnisse filtern